ARTICLE | Emerging Company Profile
Golden opportunity
How Auspherix's organogolds could allay drug-resistant infections
November 11, 2016 5:32 PM UTC
By applying medicinal chemistry to an old drug with strong but narrow-spectrum antibacterial properties, Auspherix Ltd. has discovered a new class of gold salt derivatives called organogolds that could preferentially target desired tissues to fight drug-resistant infections.
The biotech expects to enter the clinic in 2019 with one or more candidates that target and concentrate in areas in and around the bladder to treat chronic urinary tract infections (cUTI)...
BCIQ Company Profiles